{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:33:49Z","timestamp":1792103629987,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jacl.2024.04.122","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T02:36:33Z","timestamp":1712716593000},"page":"e548-e561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-850X","authenticated-orcid":false,"given":"Vera A.","family":"Bittner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2954-0695","authenticated-orcid":false,"given":"Gregory G.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrance","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Asita","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-2440","authenticated-orcid":false,"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McGinniss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pordy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0486-6325","authenticated-orcid":false,"given":"Genevieve","family":"Garon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Scemama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-2941","authenticated-orcid":false,"given":"Ph. Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-0264","authenticated-orcid":false,"given":"Michael","family":"Szarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.jacl.2024.04.122_bib0001","doi-asserted-by":"crossref","first-page":"e1059","DOI":"10.1161\/CIR.0000000000001071","article-title":"Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the american heart association","volume":"145","author":"Wenger","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.04.122_bib0002","first-page":"17","article-title":"Adequate enrollment of women in cardiovascular drug trials and the need for sex-specific assessment and reporting","author":"Carland","year":"2022","journal-title":"American Heart Journal Plus: Cardiology Research and Practice"},{"issue":"9976","key":"10.1016\/j.jacl.2024.04.122_bib0003","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.04.122_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society","author":"Roeters van Lennep","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.04.122_bib0005","first-page":"30939","article-title":"Sex-specific predictors of PCSK9 levels in a European population: the IMPROVE study","author":"Ferri","year":"2020","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2024.04.122_bib0006","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/FJC.0000000000001205","article-title":"Sex differences in low-density lipoprotein cholesterol reduction with PCSK9 inhibitors in real-world patients: the LIPID-REAL registry","volume":"79","author":"Cordero","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"10.1016\/j.jacl.2024.04.122_bib0007","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/2047487320902750","article-title":"LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial","volume":"28","author":"Sever","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"39","key":"10.1016\/j.jacl.2024.04.122_bib0008","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a european atherosclerosis society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.jacl.2024.04.122_bib0009","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2024.04.122_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.118.038840","article-title":"Effect of alirocumab on mortality after acute coronary syndromes","volume":"140","author":"Steg","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2024.04.122_bib0011","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ahj.2014.07.028","article-title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial","volume":"168","author":"Schwartz","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacl.2024.04.122_bib0012","first-page":"18499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.jacl.2024.04.122_bib0013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","article-title":"Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome","volume":"75","author":"Bittner","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacl.2024.04.122_bib0014","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10985-019-09462-4","article-title":"Modeling marginal features in studies of recurrent events in the presence of a terminal event","volume":"25","author":"Andersen","year":"2019","journal-title":"Lifetime Data Anal"},{"issue":"1","key":"10.1016\/j.jacl.2024.04.122_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2024.04.122_bib0016","first-page":"35576","article-title":"Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: the Copenhagen General Population Study","author":"Simony","year":"2022","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jacl.2024.04.122_bib0017","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jvs.2015.08.114","article-title":"Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis","volume":"63","author":"Forbang","year":"2016","journal-title":"J Vasc Surg"},{"issue":"18","key":"10.1016\/j.jacl.2024.04.122_bib0018","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs","volume":"71","author":"Scott","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacl.2024.04.122_bib0019","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women's participation in cardiovascular clinical trials from 2010 to 2017","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacl.2024.04.122_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.whi.2015.09.002","article-title":"Gender differences in presentation, coronary intervention, and outcomes of 28,985 acute coronary syndrome patients in victoria, Australia","volume":"26","author":"Worrall-Carter","year":"2016","journal-title":"Womens Health Issues"},{"issue":"12","key":"10.1016\/j.jacl.2024.04.122_bib0021","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.cjco.2021.06.012","article-title":"Trends of sex differences in clinical outcomes after myocardial infarction in the united states","volume":"3","author":"Matetic","year":"2021","journal-title":"CJC Open"},{"issue":"16","key":"10.1016\/j.jacl.2024.04.122_bib0022","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2018.02.032","article-title":"Sex differences in high-intensity statin use following myocardial infarction in the United States","volume":"71","author":"Peters","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.jacl.2024.04.122_bib0023","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2020.08.027","article-title":"Sex differences in incident and recurrent coronary events and all-cause mortality","volume":"76","author":"Peters","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jacl.2024.04.122_bib0024","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.jacc.2019.09.065","article-title":"Outcomes of women compared with men after non-st-segment elevation acute coronary syndromes","volume":"74","author":"Sarma","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.04.122_bib0025","article-title":"Relating Lipoprotein(a) concentrations to cardiovascular event risk after acute coronary syndrome: a comparison of three tests","author":"Szarek","year":"2023","journal-title":"Circulation"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424001697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424001697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T23:49:02Z","timestamp":1724975342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424001697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1933287424001697"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.04.122","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.04.122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}